It turns RNA analysis data into visualizations that provide insights into how drugs affect RNA levels depending on dose, time, and tissue.
Arpeggio Bio is a US-based startup developing an RNA platform to guide therapeutic development.  The startup’s solution uses AI to interpret RNA time series data for signaling pathway reconstruction. It turns RNA analysis data into visualizations that provide insights into how drugs affect RNA levels depending on dose, time, and tissue.